Results 231 to 240 of about 322,632 (326)

Review on Novel Oral Therapies for Psoriasis.

open access: green, 2021
Olga Marushchak   +3 more
openalex   +1 more source

Clinical and serological characteristics of nail psoriasis in Indian patients: A cross-sectional study

open access: diamond, 2017
Deepashree Daulatabad   +5 more
openalex   +1 more source

Successful Use of Bimekizumab in Refractory Acute Generalised Exanthematous Pustulosis Triggered by Amoxicillin‐Clavulanate

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Acute generalised exanthematous pustulosis (AGEP) is a rare, acute neutrophilic dermatosis most commonly triggered by drugs, which typically resolves within 2 weeks following withdrawal of the causative agent. Topical and systemic corticosteroids remain the standard treatment.
Alexandra Junge   +5 more
wiley   +1 more source

Effectiveness of Ixekizumab in Chinese Patients with Moderate-Severe Plaque Psoriasis with Special Area Involvement: Subanalysis of a Prospective, Multicenter, Observational Real-World Study [PDF]

open access: gold
Ying Li   +14 more
openalex   +1 more source

Psoriasis and gut microbes: research advances from mechanism to therapy. [PDF]

open access: yesFront Microbiol
Chen J   +9 more
europepmc   +1 more source

Systemic Absorption and Pharmacokinetics of Five Novel Topical Dermatologic Agents: A Review

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT In recent years, innovative topical medications with novel mechanisms of action have emerged to treat common dermatologic conditions such as acne, atopic dermatitis, vitiligo, and actinic keratoses. These molecularly targeted therapies offer improved safety and tolerability compared to traditional options like corticosteroids.
Mary Dyson   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy